Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Neutropenia

• A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors
• Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers
• Lapelga vs Gastrofil
• A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
• Antimicrobial Revision in Persistent Febrile Neutropenia
• Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
• Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia
• Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast Cancer
• A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia
• Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer
• Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients
• Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia
• A Study of Amphotericin B Liposome for Injection in Patients With Persistent Neutropenia and Fever
• Empagliflozin as a Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency
• CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients
• Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia
• Safety and Efficacy of Empagliflozin in GSD1b Patients With Neutropenia
• Letermovir Use in Heart Transplant Recipients
• Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab
• Amoxicillin-clavulanate Alone or in Combination With Ciprofloxacin in Low-Risk Febrile Neutropenic Adult Patients: A Prospective, Double-blind, Randomized, Non-Inferiority Multicenter, Phase III Clinical Trial.
• Safety and Efficacy of PEG-rhG-CSF in Preventing Neutropenia in Children With Tumor After Chemotherapy
• Study on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia During Concurrent Chemoradiotherapy of Cervical Cancer
• Evaluate the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia After Chemotherapy in Patients With Non-Hodgkin's Lymphoma
• Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma
• Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2
• Efficacy of Extended Infusion of β-lactam Antibiotics for the Treatment of Febrile Neutropenia in Hematologic Patients
• Plinabulin iv Solution in Prevention of TAC Induced Neutropenia
• Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer
• Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever
• Mecapegfilgrastim Prevents Neutropenia and Radiation Esophagitis
• A Study of Mavorixafor in Participants With Severe Congenital Neutropenia and Chronic Neutropenia Disorders
• Safety, Efficacy Evaluation of Empagliflozin Administration for Neutropenia in Glycogenosis Type 1b and G6PC3 Deficiency
• Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer
• Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial
• Cost-Effectiveness Study of PEG-rhG-CSF in Prophylactic Treatment of Neutropenia After Chemotherapy in Lymphoma
• Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer
• Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients
• G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients
• Fever and Neutropenia in Pediatric Oncology Patients
• Long-acting G-CSF for Febrile Neutropenia
• Aprepitant Triple Therapy for the Prevention of CINV in Nondrinking and Young Women Who Received Moderately Emetogenic Chemotherapy
• Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents
• Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer
• Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced Neutropenia
• Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
• Efficacy of Granulocyte-Colony Stimulating Factor (G-CSF)
• Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.
• Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
• Safety and Pharmacokinetics of Intravenous and Oral APX001 in Patients With Acute Myeloid Leukemia (AML) and Neutropenia
• PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy
• Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia
• Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
• Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients
• Anakinra: Safety and Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT
• To Evaluate the Efficacy and Safety of PEG-rhG-CSF（Jinyouli®） in Reducing Neutropenia in Patients With Cervical Cancer
• Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer
• Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3
• Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant
• Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia
• SPI-2012 vs Pegfilgrastim in Management of Neutropenia in BReast Cancer Patients With Docetaxel and Cyclophosphamide
• Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
• A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia
• Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia
• PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia
• Pegteograstim in Children With Solid Tumors
• Study on Efficacy and Safety of CBLB612 for Neutropenia Prophylaxis
• The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia
• Bioavailability Study of Lozanoc™ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis
• Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer
• Evaluation of the Food Effect on the Safety, Tolerability, PK of EC-18 After Oral Administration in Healthy Volunteers
• Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia
• Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)
• SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Breast CANCEr Patients With Docetaxel and Cyclophosphamide
• A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy Participants
• Steady-State Comparative Bioavailability Study in Prophylaxis Patients of Lozanoc® 50 mg With Sporanox® 100 mg
• ANF-Rho in the Treatment of Chronic Neutropenia
• Study to Evaluate the Safety, Tolerability and PK of EC-18 After Oral Administration in Healthy Volunteers
• Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
• A Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
• A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.
• A Safety and PK Study of EC-18 in Healthy Subjects
• Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein
• Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile Neutropenia
• Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097)
• Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7%
• Biomarker and Safety Study of Clozapine in Patients With Benign Ethnic Neutropenia (BEN)
• Effect of GM1 in Prevention of Oxaliplatin Induced Neurotoxicity in Stage II/III Colorectal Cancer
• Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive Lymphoma
• Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome
• Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile Neutropenia
• A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement
• Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies
• Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO
• A Trial of MB-6 for Reduction of Neutropenia Induced by Chemotherapy in Patients With Stage III Colorectal Cancer.
• A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy
• A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutropenia
• Study of Danggui Buxue Decoction in Preventing Neutropenia
• Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy
• Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia
• Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia
• Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia
• Bone Marrow Transplant With Abatacept for Non-Malignant Diseases
• Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia
• Cologne Cohort of Neutropenic Patients (CoCoNut)
• Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®
• Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients
• Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia
• Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation
• A Study of Empirical Antifungal Therapy With Itraconazole
• Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia
• Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile Neutropenia
• Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer
• Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
• Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients
• Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia
• Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
• A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy
• Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and Neutropenia
• Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy
• A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy
• Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
• Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim
• Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim
• Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
• Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
• Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients
• Decitabine for High-Risk Sickle Cell Disease
• Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
• Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases
• Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation
• Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia
• Study to Improve Survival Among HIV-Exposed Infants in Botswana
• SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients
• Daptomycin Versus Placebo in Patients With Neutropenia and Fever
• Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome
• Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
• A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia
• Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy
• Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation
• Neugranin in Breast Cancer Patients Receiving Doxorubicin/Docetaxel (NEUGR-003)
• A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen
• Safety of Cotrimoxazole in HIV- and HAART-exposed Infants
• A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer
• Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients
• AMD 3100 for Treatment of Myelokathexis
• The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants
• Validation of an Index of Neutropenia (D-index) in Febrile Neutropenic Cancer Patients
• A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
• Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options
• Procalcitonin Protocol to Shorten the Antibiotic Therapy in Febrile Neutropenia
• PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
• Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia
• Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia
• Neugranin in Breast Cancer Patients Receiving Doxorubicin/Docetaxel
• An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System
• A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection
• Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer
• Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer
• Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)
• Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study)
• Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055)
• G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer
• Various G-CSF Regimens to Prevent Infection During Chemotherapy
• A Study of Ceftobiprole in Patients With Fever and Neutropenia.
• A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia
• Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia
• Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation
• Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients
• Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia
• Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics
• Sirolimus for Autoimmune Disease of Blood Cells
• A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED)
• Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients
• Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
• Daptomycin in Treating Neutropenia and Fever in Patients With Cancer
• Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in Firs
• Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders
• Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy
• Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease
• Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042)
• A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer
• Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia
• The Tobramycin Study
• Prevention Trial of Nosocomial Infections in Neutropenic Prematures With G-CSF
• Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin
• Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia
• Stem Cell Transplant for Bone Marrow Failure Syndromes
• Stem Cell Transplant for Hemoglobinopathy
• A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children
• Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia
• Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases
• Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children
• Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)
• Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting
• MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044)
• Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
• Anidulafungin in Treating Immunocompromised Children With Neutropenia
• Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy
• Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
• Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17
• Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)
• Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy
• Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy
• Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection
• Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
• Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia
• Caspofungin Acetate in Treating Children With Fever and Neutropenia
• BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy
• Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
• Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders
• Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia
• Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma
• Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
• Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer
• Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
• Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma
• Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia
• Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia
• SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
• Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
• A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine
• A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.
• Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia
• Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis
• Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine
• A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer